Ewing sarcoma: Similar survival rates with intensified dose regimen of VDC/IE
How to Cite
OrthoEvidence. Ewing sarcoma: Similar survival rates with intensified dose regimen of VDC/IE. ACE Report. 2013;2(7):611. Available from: https://myorthoevidene.com/AceReport/Report/5096
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group StudyJ Clin Oncol. 2009 May 20;27(15):2536-41. doi: 10.1200/JCO.2008.19.1478. Epub 2009 Apr 6
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
478 patients under the age of 30, diagnosed with non-metastatic ESFT (or the Ewing sarcoma family of tumours), were randomized to either a standard or intensified dose regimen of vincristine, doxorubicin, and cyclophosphamide (VDC) along with ifosfamide and etoposide (IE) to assess the 5-year event-free and overall survival rates between groups. Results indicated that there was no significant diff...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE